TARA - Protara Therapeutics GAAP EPS of -$0.80 May, 04 2023 01:36 PM ArTara Therapeutics Inc. 2023-05-04 13:36:07 ET Protara Therapeutics press release ( NASDAQ: TARA ): Q1 GAAP EPS of -$0.80. Continue to expect cash, cash equivalents and investments of $90M as of March 31, 2023 to fund operations into 2025 For further details see: Protara Therapeutics GAAP EPS of -$0.80